Graypoint LLC Buys Shares of 50,035 Option Care Health, Inc. (NASDAQ:OPCH)

Graypoint LLC purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 50,035 shares of the company's stock, valued at approximately $1,161,000.

A number of other large investors have also added to or reduced their stakes in the stock. FMR LLC increased its holdings in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the period. Massachusetts Financial Services Co. MA purchased a new stake in shares of Option Care Health during the 2nd quarter valued at $68,003,000. Victory Capital Management Inc. increased its stake in Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock valued at $50,756,000 after acquiring an additional 1,585,818 shares during the last quarter. Magnetar Financial LLC raised its position in Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company's stock valued at $68,750,000 after purchasing an additional 1,377,929 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after purchasing an additional 1,328,326 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Down 0.6 %

NASDAQ OPCH traded down $0.15 during trading hours on Friday, reaching $23.99. 1,842,414 shares of the company's stock traded hands, compared to its average volume of 1,480,236. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a 50-day simple moving average of $23.10 and a 200 day simple moving average of $27.70. The firm has a market cap of $4.08 billion, a PE ratio of 20.16, a PEG ratio of 2.43 and a beta of 1.31.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OPCH. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities restated a "market outperform" rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday. The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, Barrington Research cut their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a report on Thursday, October 31st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $29.14.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.